160 related articles for article (PubMed ID: 36528916)
1. NMNAT2: An important metabolic enzyme affecting the disease progression.
Li W; Gao M; Hu C; Chen X; Zhou Y
Biomed Pharmacother; 2023 Feb; 158():114143. PubMed ID: 36528916
[TBL] [Abstract][Full Text] [Related]
2. Mitochondrial impairment activates the Wallerian pathway through depletion of NMNAT2 leading to SARM1-dependent axon degeneration.
Loreto A; Hill CS; Hewitt VL; Orsomando G; Angeletti C; Gilley J; Lucci C; Sanchez-Martinez A; Whitworth AJ; Conforti L; Dajas-Bailador F; Coleman MP
Neurobiol Dis; 2020 Feb; 134():104678. PubMed ID: 31740269
[TBL] [
